학술논문
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy.
Document Type
Article
Author
Jackson, Jeffrey J.; Shibuya, Grant M.; Ravishankar, Buvana; Adusumilli, Lavanya; Bradford, Delia; Brockstedt, Dirk G.; Bucher, Cyril; Bui, Minna; Cho, Cynthia; Colas, Christoph; Cutler, Gene; Dukes, Adrian; Han, Xinping; Hu, Dennis X.; Jacobson, Scott; Kassner, Paul D.; Katibah, George E.; Ko, Michelle Yoo Min; Kolhatkar, Urvi; Leger, Paul R.
Source
Journal of Medicinal Chemistry; 10/13/2022, Vol. 65 Issue 19, p12895-12924, 30p
Subject
Language
ISSN
00222623